Malaysia's aging population brings in revenue to the pharmaceutical industry

• Industry growth mirrors great job opportunities for future pharmacists; Pharmacists are in high demand in Malaysia with a ratio to population of about 1:4000
• Annual revenue this year is expected to hit RM1.108 billion, higher than last year's RM1.063 billion

Malaysia’s generic pharmaceutical manufacturing industry is expected to see US$365 million (RM1.108 billion) in total annual revenue by end-2012, said the Malaysian Organisation of Pharmaceutical Industries (MOPI).

Last year, the industry recorded slightly over US$350 million (RM1.063 billion) in revenue and it is growing about six to eight percent annually.

“For this year, the main driver to growth is the aging population, a better detection rate, and newer medication with high value,” said MOPI President, Leonard Ariff Abdul Shatar.Malaysia’s generic pharmaceutical manufacturing industry is expected to see US$365 million (RM1.108 billion) in total annual revenue by end-2012, said the Malaysian Organisation of Pharmaceutical Industries (MOPI).

Last year, the industry recorded slightly over US$350 million (RM1.063 billion) in revenue and it is growing about six to eight percent annually.

“For this year, the main drivers to growth is the aging population, a better detection rate, and newer medication with high value,” said MOPI President, Leonard Ariff Abdul Shatar.